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The purpose of this study was to compare physicians’, midwives’ and lay people’s attitudes towards
genetic screening and testing to find out whether medical education and experience influence attitudes of
genetic screening and testing. The study was based on comparison of answers to joint questions in three
different cross-sectional postal surveys between October 1996 and April 1998 in Finland. Target groups
were physicians (study base n¼772, response rate 74%, including gynaecologists, paediatricians, general
practitioners and clinical geneticists), midwives and public health nurses (collectively referred to as
midwives in the following; n¼800, response rate 79%), and lay people (n¼2000, response rate 62%).
Midwives were more worried about the consequences of genetic testing and stressed the autonomy of the
customer more strongly than lay people did. Furthermore, professionals considered that lay peoples’
expectations as regards to genetic testing are too high. Having more medical education was related to
having less ‘cannot say’ and missing responses. Our results do not suggest that major conflicts about the
direction of genetic testing and screening would arise in near future. However, different positions and
interests should be considered. Reporting in public about new prospects and developments in medical
genetics should pay more attention also to concerns for balancing promises and drawbacks.
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Introduction
Different actors in health care have varying education,
experience and roles as regards genetic screening and
testing. Education and experiences may be associated with
attitudes and understanding, and may have implications
for information provision and for clients’ decision-making
and participation in screening and testing.
One of the roles of medical practitioners is to introduce
and launch new technology. Health care professionals are
gatekeepers of medical technology, strongly influencing
how and when such technology is used. For example,
physicians’ attitudes have implications for the introduc-
tion and continuation of genetic screening.1–2 In Finland,
midwives and public health nurses do not make health-
policy decisions, but they transfer medical knowledge to
lay people by providing health education and by counsel-
ling clients. They also have a central role in maternity and
prenatal care and in prenatal diagnosis,3 areas in which
genetic screening and testing have been much discussed.
Most of the earlier studies on attitudes towards genetics,
genetic screening or genetic testing have not been
comparative but conducted either among physicians or
among lay people.4 – 12 Usually, studies have not covered
attitudes more widely but focused on one specific diseaseReceived 28 March 2002; revised 6 March 2003; accepted 11 March 2003
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or problem.5 – 12 We found only two studies comparing
professionals’ and lay people’s attitudes, both from the
early 1990s in England. One study13 compared the
attitudes of professionals, relatives and other members of
the public towards cystic fibrosis (CF) carrier screening.
In that study, large support for screening was found both
among professionals and among lay people although low
knowledge of CF in the latter group. The second study14
compared attitudes of professionals and public towards
developments in genetic testing in pregnancy and deci-
sion-making. In that study, genetic applications were
found to evoke both positive and negative feelings among
both professionals and lay people, but lay people were
more negative.
It is important to compare on the one hand attitudes
towards genetics between different professional groups and
on the other hand between health care professionals and
lay people. It is possible that in health care, in maternity
care for example, contradictions and even conflict arise
because of varying expectations and worries about genetic
testing. Furthermore, in circumstances where the applica-
tions of genetic testing or screening are under negotiation,
it is vital to understand the standpoints of all groups
involved.
At the time of our study, genetic screening was not used
in clinical practice in Finland. Earlier in the 1990s an
antenatal screening programme for INCL, aspartylglucosa-
minuria (AGU) and fragile-X was experimented in mater-
nity clinics.1 Genetic testing for colon and breast–ovarian
cancer was performed among at-risk groups quite actively.
The purpose of this article is to compare Finnish physi-
cians’, midwives’ and lay people’s attitudes towards genetic
screening and testing to find out whether medical educa-
tion and experience influence attitudes of genetic screen-
ing and testing.
Materials and methods
The study materials were collected from three different
questionnaire surveys conducted among physicians, mid-
wives and lay people in Finland.
In November 1996, questionnaires were mailed to
gynaecologists and paediatricians, including both leading
physicians (all professors of gynaecology and obstetrics and
of paediatrics and all specialist head physicians of hospital
obstetric and paediatric units, n¼ 122) and a random
sample of ordinary practitioners (gynaecologists, n¼176;
paediatricians, n¼208).15 – 16 Additionally, all clinical ge-
neticists in Finland (n¼ 21) and a random sample of
general practitioners (n¼245) were included. One remin-
der was mailed in January 1997. Overall, 561 (74%)
physicians answered.
In February 1998, questionnaires were mailed to a
random sample of 400 midwives and 400 public health
nurses (subsequently all of them are referred to as mid-
wives).17 One reminder was mailed in April 1998. Overall,
646 midwives responded (81%). Excluding the 75 mid-
wives who returned an empty form with an explanation
that they do not work or have never worked as a midwife or
public health nurse in maternity care, left 571 midwives
(79%).
Between October 1996 and January 1997, questionnaires
were mailed to a random sample of 2000 Finnish adults
aged 16–65.18 – 19 After two reminders, 1240 (61%) an-
swered. In this comparative study, we excluded health
professionals from the sample in order to have a pure lay
sample. Also, those younger than 23 years old and older
than 65 years old were excluded to make the sample
comparable with the two professional surveys, leaving a
final total of 1050 respondents.
The physician questionnaire contained multiple-choice
and open-ended questions on prenatal and genetic screen-
ing (Appendix). Genetic screening was defined as screening
a general population, and genetic testing as testing selected
individuals because of, for example, their family history,
for (1) a future disease or predisposition to a disease or
characteristic, or (2) carrier status of a disease or character-
istic. The midwife questionnaire was a modified version of
the physician questionnaire, and included additional
questions from the lay people survey. Lay people ques-
tionnaire included general questions on genetics, and
questions specifically on prenatal diagnosis, genetic testing
and abortion.
There were three joint questions for physicians and
midwives, four joint questions for midwives and lay
people, and one joint question for all groups. Professionals’
opinions on genetic screening were studied with a
hypothetical, future-oriented question (Question 1 in the
Appendix), and their attitudes towards medical technology
were measured by asking for levels of agreement with a
provided statement (Question 2). Additionally, we listed
different aspects related to genetic screening and asked
physicians to choose those about which they especially
would like to educate lay people (Question 3). Midwives’
and lay people’s attitudes towards genetic testing during
pregnancy were explored with an example case of parents
declining a recommended genetic test (Question 4), and
their attitudes towards genetic tests and disability were
measured in terms of agreement with provided statements
(Questions 5–7). The interest of all respondents in
knowing their own risks for hereditary diseases was
investigated by asking them to estimate the possibility
that they would participate in a genetic test (Question 8).
Statistical testing of differences between the groups was
performed using the w2 test. In comparisons, the group
having most medical education was chosen for the
reference group. Since all midwives except one were
women (Table 1), we also compared midwives to female
physicians and lay women.
Attitudes towards genetic screening and testing
H Toiviainen et al
566
European Journal of Human Genetics
Results
Table 1 describes the respondents’ background character-
istics. The mean age of physicians was 47 years (min 32 and
max 65), that of midwives 41 years (min 23 and max 58)
and that of lay people 43 years (min 23 and max 65).
Physicians and midwives
Both physicians and midwives were more inclined towards
selective genetic testing rather than screening the general
population, with the exception of screening for breast
cancer and juvenile diabetes (Table 2). More physicians
than midwives wanted to screen for predisposition to
familial hypercholesterolaemia, but more were of the
opinion that neither screening nor testing should be done
as regards to juvenile diabetes, adult-onset diabetes and
schizophrenia. Furthermore, there were more midwives
than physicians who did not answer these questions.
When asked, whether they thought it is probable that
during the next 10 years will take part in a genetic test,
only a minority of physicians and midwives said that they
will probably take part (Table 3). Physicians more often
than midwives regarded that it is unlikely.
The majority of both physicians and midwives consid-
ered lay people’s expectations of medical technology to be
too high (Table 4). Female physicians answered in the same
way as all physicians.
Professionals and lay people
Responses to the example case of parents declining a
recommended genetic test showed that both midwives and
lay people valued parents’ autonomy, but more midwives
than lay people did so and midwives also more often than
lay people were tolerant and understanding towards the
couple’s decision not to take the suggested gene test
(Table 5). However, when asked about their personal
choices in a corresponding situation, midwives’ responses
resembled those of lay people. Lay women’s and men’s
answers were relatively similar.
Midwives less often than lay people were of the opinion
that with genetic tests one may increase people’s control
over their lives and more often worried that genetic testing
may lead to eugenics (Table 6). In other words, it seems
that there was more optimism among lay people and more
scepticism among midwives.
Table 1 Respondents’ background characteristics (%)
Physicians (n=561) Midwives (n=571) Lay people (n=1050)
Works in health care 96 76*** 0
Educationa
High 100 0 9
Middle 0 100 47
Low 0 0 26
No information 0 0 18
All 100 100 100b
Women 49 99*** 51 NS
aHigh=university degree, middle=lower or higher vocational school, low=no degree after the basic education.
bIn testing distribution, midwives and lay people were tested against physicians, and ‘no information’ group was excluded.
***Po0.001, NS=not statistically significant.
Table 2 Proportions of physicians (n=561) and midwives (n=571) who were in favour of genetic screening (%) (Appendix,
Question 1)
Screening for some target group Testing only Neither screening nor testinga
Phy. Mid. Phy. Mid. Phy. Mid. P-value
Breast cancer 45 42 36 34 14 15 NS
Familial hypercholesterolaemia 40 28 47 44 9 17 ***
Juvenile diabetes 39 40 36 37 20 13 *
Colon cancer 35 30 47 42 13 16 NS
Adult-onset diabetes 28 25 34 39 32 25 *
Huntington’s disease 19 14 49 47 21 16 NS
Schizophrenia 18 13 28 39 47 36 ***
a‘No information’ group is not shown. In testing distributions, midwives were tested against physicians, and ‘no information’ groups were excluded.
*Po0.05, ***Po0.001, NS=not statistically significant.
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Furthermore, midwives less often chose the ‘don’t know’
option than did lay people.
When asked, whether it is probable that they will during
the next 10 years will take part in a genetic test, there was a
clear difference between the professionals and lay people in
the certainty of the estimation; about 40% of lay people
did not estimate this probability compared to just over
12% of professionals (Table 3). If only those expressing an
estimation (ie excluding ‘don’t know’ and no information)
were considered, 18% of physicians, 23% of midwives and
Table 3 Distribution of respondents by their estimation that they will participate in a genetic test
within the next 10 years (%) (Appendix, Question 8)
Physicians (n=561) Midwives (n=571) Lay people (n=1050)
Probably 16 19 10
Unlikely 72 62 49
Cannot say 11 14 39
No information 1 5 2
All 100 100* 100***
Midwives and lay people were tested against physicians, and ‘no information’ groups were excluded. *Po0.05,
***Po0.001.
Table 4 Physicians’ and midwives’ opinions of lay-people’s expectations (%) (Appendix, Question 2)
Physicians (n=561) Midwives (n=571)
The public’s expectations of medical technology are too high
Agree 76 62
Disagree 16 19
Cannot say 7 12
No information 1 7
All 100 100***
In testing distribution, midwives were tested against physicians, and ‘no information’ groups were excluded. ***Po0.001.
Table 5 Distribution of midwives’ and lay people’s answers in the example case of parents declining a recommended
genetic test (%)a (Appendix, Question 4)
Midwives (n=571) All lay people (n=1050) Lay women (n=534)
The solution may be the best possible for them
Agree 75 42 45
Disagree 8 41 39
Cannot say 9 14*** 13***
They have a full right to make such a decision
Agree 93 78 82
Disagree 1 13 11
Cannot say 0 6*** 4***
If I were in their situation, I would do the same
Agree 24 21 22
Disagree 48 57 57
Cannot say 21 19* 18*
The solution is wrong for the child
Agree 15 35 34
Disagree 55 37 40
Cannot say 22 24*** 22***
The parents are not considerate
Agree 7 33 29
Disagree 77 46 52
Cannot say 9 17*** 16***
Couples like this should not have children at all
Agree 2 16 13
Disagree 84 65 69
Cannot say 6 16*** 16***
a‘No information’ (2–8%) group is not shown. In testing distributions, lay people and lay women were tested against midwives, and ‘no information’
groups were excluded. *Po0.05, ***Po0.001.
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17% of lay people said it is probable that they will
participate in a genetic test.
Physicians wanted to educate lay people about the
aspects related to genetic screening as follows: sensitivity
and specifity of screening (false negatives and positives)
(65% of the physicians), concepts of risks and probability
(64%), clinical picture of the screened disease (49%),
advantages of knowing one’s own prospects (40%), influ-
ence of heredity and the environment on health (36%),
ethical consequences of genetic screenings (35%), disad-
vantages of knowing one’s own prospects (30%), social
consequences of genetic screening (21%), consequences of
screening and findings for health care resources (10%).
Discussion
In summary, our results suggest that although in many
respect physicians’, midwives’ and lay people’s attitudes
resemble each other, there are also significant differences.
First, midwives were more worried about the consequences
of genetic testing and stressed the autonomy of the
customer more strongly than lay people did. Second,
having more medical education was also related to having
less ‘cannot say’ and missing responses.
The two professional surveys were planned to be
comparative, but the lay-person survey was independent.
However, the midwife questionnaire was made after the lay
survey, and some joint questions were used. Professionals’
response rates were high, but lay people’s response rate
only moderate. The midwife survey was made 16 months
later than the other two surveys. During those 16 months
no major breakthroughs or public discussion of genetic
screening or testing occurred in Finland. A research
screening of diabetes susceptibility among newborns was
started, but it was not much discussed. Hence, it is unlikely
that differences in attitudes between the groups studied
could be explained as a reaction to public disputes or major
changes in the way medical genetic is applied in health
care.
In a study by Michie et al14 in England in early 1990s lay
people had more negative attitudes towards genetic
applications than the professional groups. In our study,
the opposite result was found. Previously, Finnish lay
people’s critical attitudes towards genetic testing have been
found to be associated with higher education level and
higher socio-economic status,18,20 – 21 and better knowl-
edge about basic genetics has been found to be related to
both more enthusiasm and more scepticism.19 Compar-
isons between countries, however, are difficult; differences
in attitudes between countries may be explained by
different traditions of reliance on medical specialists and
lack of critical debate and dialogue.22
It has been previously found that Finnish women have a
more critical attitude towards genetic tests than men.21
Analysis by gender showed that the differences between
our study populations were not because of all midwives
having been women.
In a study by Friedman et al23 in 1996 in Texas, a
minority of primary care physicians reported ever having
referred a patient for a genetic evaluation for cancer risk. In
our study, the proportions of physicians and midwives
supporting hypothetical screening were smaller than in
that study. In some studies carried out in the 1990s in the
USA, both patients, members of at-risk families and the
general public have been very interested in genetic testing
for cancers of the breast,5 of the breast and ovaries,11–12
and of the colon,6 even though lower willingness to
participate has been reported in other studies.8–9 In a
Finnish study by Hietala et al24 both the public in general
as well as family members of AGU (aspartylglucosaminuria)
patients had favourable attitudes towards genetic tests and
wide offering of the tests was accepted.
In our study, a majority of professionals and lay people
said that it is unlikely that they would participate in a
genetic test in the near future. Indeed, since the mid-1990s
Table 6 Midwives’ and lay people’s attitudes towards genetic tests and disability (%) (Appendix, Questions 5–7)
Midwives
(n=571)
All lay people
(n=1050)
Lay women
(n=534)
With genetic tests one may increase people’s control over their lives
Agree 46 63 64
Disagree 39 13 15
Cannot say 10 21*** 18***
To have a disabled child is a disaster for the family
Agree 17 31 28
Disagree 68 53 56
Cannot say 9 14*** 13***
I am worried that genetic tests may lead to eugenics
Agree 68 51 57
Disagree 22 31 27
Cannot say 4 15*** 13***
In testing distributions, lay people and lay women were tested against midwives, and ‘no information’ groups were excluded. ***Po0.001.
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there has been only a few genetic screening or testing
programmes in Finland, and thus the actual likelihood to
participate in one is quite small. However, we should bear
in mind that in these few programmes (genetic screening
in maternity centre, neonatal diabetes screening, genetic
cascade screening in cancer families) the uptake rate has
been quite high, that is, 80–90%25 – 26 and susceptibility
testing for common diseases is expected to become the
main type of test in the near future.27 Hence, despite the
result that most respondents in all groups considered it
improbable to uptake a gene test, genetic testing is steadily
increasing in health care.
Regarding genetic testing during pregnancy, midwives
were permissive toward parents’ autonomy, and accepted
the solution to decline the suggested gene test more often
than did lay people. Midwives’ attitudes are probably
because of the professional norms emphasising non-
directiveness in genetic counselling – a norm that has
been strongly emphasised in respect of genetic testing and
prenatal diagnostics during the 1990s. However, it is
important to note that although midwives were tolerant
as regards to other people’s decisions, only a minority of
them would themselves decline the suggested gene test. In
respect of own choices midwives resembled lay people.
We found out that lay people are more tended to choose
‘don’t know’ responses than the professional groups.
Turner and Michael28 have argued that ‘cannot say’
responses to a knowledge and attitudes questions have
different meanings, including real ignorance, unwilling-
ness to answer, professional knowledgeable and ambiva-
lent attitude or a potent political statement (deliberate
choice not to answer). It is also a cultural phenomenon
varying, for example, between countries. Turner and
Michael continue that in science ‘cannot say’ responses
can be employed by people to express their identity
through their relationship with the ambivalent role of
science. Currently, medical genetics is an area where
development is rapid and where there are great variations
in tests specifics and their implications. This situation may
cause uncertainty among some individuals.
In our study, one of the key differences between the
groups was the varying degrees to which the ‘cannot say’
option was used; midwives compared to physicians, and
lay people compared to midwives gave more ‘cannot say’
and missing responses. It is possible that different groups
with different medical education and experience under-
stood the questions differently. However, it is not necessa-
rily solely a question about knowledge but a qualitative
difference between health care professionals’ and lay
people’s attitudes; the first express professional opinions
and the latter express personal thoughts. According to
Skelton and Croyle,29 professionals use information which
is not available to nonexperts, or use different decision-
making rules. Furthermore, Croyle and Jemmott30 have
argued that physicians’ opinions, unlike lay people’s, are
not connected to personal health history. It is noteworthy
that in the question concerning personal choices about
genetic testing during pregnancy, midwives chose the
‘cannot say’ option as often as did lay people. The topic
became more difficult as it became more salient and it was
not possible to appeal so professional opinions and
standards.
There were some differences between midwives and
physicians as regards to attitudes towards testing and
screening of various diseases. These differences, however,
do not suggest that major conflicts about the direction of
genetic testing and screening would arise in near future.
Still, midwives’ or other groups’ possible concerns over
genetic testing should be listened to in health care.
Furthermore, we were satisfied to see that midwives took
the principle of health care consumers’ autonomy ser-
iously. Other studies have shown that lay people indeed are
of the opinion that gene tests should be voluntary and a
private matter.19 However, further research is needed to
examine whether the principle of autonomy is actualised
in genetic counselling.
Our study indicates that lay people’s expectations as
regards to genetic testing are too high – at least this is how
the professionals under study here saw the situation. We
suggest that in the future, when reporting in public about
medical genetics, both new prospects and developments as
well as drawbacks and delays (temporal, financial, attitu-
dinal) should be considered. For example, the introduction
of genetic screenings in Finnish health care has not been as
rapid as was expected among the geneticists’ community
in the early 1990s.31 It might be that the early enthusiasm
among the physicians themselves is reflected in lay
people’s more straightforward attitudes. For balancing the
promises and drawbacks of new genetics, media as well as
health professionals and researchers are important actors.
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Appendix: Questions
Physicians and midwives
Question 1. If it becomes technically possible to genetically
screen for the following diseases and/or for the predisposi-
tion to them, for which diseases and for whom would it be
good to be screen? (you may circle many)
Nobody Only on the
grounds of
family history
Screening of
The whole
population
Fetuses Newborns School
pupils
Men in
military
service
1. Juvenile diabetes (Type I)........ 1 2 3 4 5 6 7
2. Adult-onset diabetes (Type II) 1 2 3 4 5 6 7
3. Familial hypercholesterolaemia 1 2 3 4 5 6 7
4. Schizophrenia....................... 1 2 3 4 5 6 7
5. Finnish heritage diseases........ 1 2 3 4 5 6 7
6. Breast cancer (women)............ 1 2 3 4 5 6
7. Colon cancer....................... 1 2 3 4 5 6 7
8. Huntington’s disease.......... 1 2 3 4 5 6 7
Respondents were classified as supporters of screening if screening was suggested for any of the target groups.
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In the data the options ‘Completely agree’ and ‘Agree’ were combined into a category ‘Agree’ and the options ‘Completely disagree’ and
‘Disagree’ into a category ‘Disagree’.
Question 3. Which of the following aspects related to genetic screening you would especially like to educate lay people about ?
(you may circle many)
1. Sensitivity and specifity of screening (false negatives and positives)
2. Concepts of risks and probability
3. Clinical picture of the screened disease
4. Consequences of screening and findings for health care resources
5. Influence of heredity and the environment on health
6. Advantages of knowing one’s own prospects
7. Disadvantages of knowing one’s own prospects
8. Social consequences of genetic screening
9. Ethical consequences of genetic screening
10. Other, what ? ___________________________________
Midwives and lay people
Question 4. Let’s consider a situation in which a couple has a 25% probability to have a severely mentally retarded child. The
woman is now three months pregnant. However, the couple refuses to take part in the genetic test their doctor suggests. What
do you think about the situation?
In the data the options ‘Completely agree’ and ‘Agree’ were combined into a category ‘Agree’ and the options ‘Completely disagree’ and
‘Disagree’ into a category ‘Disagree’.
All groups
Question 8. Do you think that during the next 10 years, you will take part in a genetic test?
1. Very probably
2. Quite probably
3. Quite unlikely
4. Very unlikely
5. Cannot say
In the data the options ‘Very probably’ and ‘Quite probably’ were combined into a category ‘Probably’ and the options ‘Very unlikely’
and ‘Quite unlikely’ into a category ‘Unlikely’.
Question 2. Completely
agree
Agree Disagree Completely
Disagree
Cannot Say
The public’s expectations of medical technology
are too high
1 2 3 4 5
Completely
agree
Agree Disagree Completely
Disagree
Cannot say
1. The solution may be the best possible for them 1 2 3 4 5
2. They have a full right to make such a decision 1 2 3 4 5
3. If I were in their situation, I would do the same 1 2 3 4 5
4. The solution is wrong for the child 1 2 3 4 5
5. The parents are not considerate 1 2 3 4 5
6. Couples like this should not have children at all 1 2 3 4 5
Question 5. Completely
agree
Agree Disagree Completely
disagree
Cannot say
With genetic tests one may increase people’s control
over their lives
1 2 3 4 5
Question 6. Completely
agree
Agree Disagree Completely
disagree
Cannot say
To have a disabled child is a disaster for the family 1 2 3 4 5
Question 7. Completely
agree
Agree Disagree Completely
disagree
Cannot say
I am worried that genetic tests may lead to eugenics 1 2 3 4 5
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